Recent TXG Stock Price | TXG Stock Predictions | |
$36.89 | +49.55% |
$55.17 |
Recent TXG Analyst Ratings Breakdown, Making TXG Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 11 | 11 | 11 | 11 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 3 | 3 | 3 | 3 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 1 | 1 | 1 | 1 |
Average rating: | 1.66 | 1.66 | 1.66 | 1.66 |
For the TXG stock predictions from the analysts covering 10x Genomics Inc, we have collected all of the individual TXG stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 15 different analysts covering TXG (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since TXG stock predictions may vary widely, another useful metric to consider is the median TXG stock prediction, which represents the price at which half of the analysts
made TXG stock predictions that were higher and half made TXG stock predictions that were lower. This makes for a different take on the TXG stock predictions out there, as compared to average or mean.
And that median across all the individual TXG stock predictions was: $60.0 as of 2024-03-28.
The very highest of the TXG stock predictions for one year price target was $70.0, while the very lowest of the TXG stock predictions in the analyst group was
$21.5 (with a standard deviation of $13.669). Get the latest Zacks research report on TXG — FREE
Find out: TXG next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
AXTI Stock Predictions
OR Stock Predictions
MSM Stock Predictions
FCAU Stock Predictions
IRBT Stock Predictions
CW Stock Predictions
RIOT Stock Predictions
VZ Stock Predictions
AVY Stock Predictions
|
|
Buy (3.34 out of 4) 53rd percentile
(ranked higher than approx. 53% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |